Lantern Pharma Inc narrowed first quarter of 2023 net loss per share of $-0.36 compare to net loss per share of $-0.38 recorded in the same quarter a year ago a decrease compare to $-0.31 realized in previous quarter.
first quarter of 2023
Earnings Per Share
Revenues
$ -0.36
$
0 Mill
$+0.02
Unch.
Lantern Pharma Inc 's Revenue
fell by
0 % in first quarter of 2023 (Mar 31 2023) year on year,
to $0 million and
declined by
sequentially.
Lantern Pharma Inc is Expected to report next financial results on August 07, 2023.
Lantern Pharma Inc 's
in thefirst quarter of 2023 recorded net loss of $-3.868 million, an improvement compare to net loss of $-4.122 million in I. Quarter a year ago.
